Dr. Thomas Gajewski on Analyzing the Tumor Microenvironment to Guide Immunotherapy in Melanoma

Cancer Network spoke with Thomas Gajewski, MD, PhD, of the University of Chicago Medical Center, about analyzing the tumor microenvironment to guide immunotherapy in melanoma.

Related Content:

ASCO MelanomaMelanoma

First-Line Nivolumab Plus Ipilimumab Improves OS Versus Chemo in Patients with Metastatic Uveal Melanoma

Study Identifies Shift in Incidence of Second Primary Cancers in Patients with Metastatic Melanoma

FDA Grants Orphan Drug Designation to PVSRIPO for Treatment of Advanced Melanoma